Table 1. Baseline characteristics of the study participants (N=952).
| Variables | Survived (n=859) | Died (n=93) | P value |
|---|---|---|---|
| Hospitalization (days) | 14.3±7.6 | 14.4±7.7 | 0.53 |
| Preoperative variables | |||
| Age (years) | 50.7±11.9 | 54.2±13.3 | 0.02 |
| Male | 616 (71.7) | 65 (69.9) | 0.71 |
| EuroSCORE II (%) | 6.3±2.8 | 8.2±3.3 | 0.042 |
| History of surgery | 145 (16.9) | 18 (19.4) | 0.75 |
| History of CHD | 72 (8.4) | 8 (8.6) | >0.99 |
| Hypertension | 620 (72.2) | 65 (69.9) | 0.74 |
| Diabetes | 41 (4.8) | 5 (5.4) | 0.82 |
| Hyperlipidemia | 332 (38.6) | 39 (41.9) | 0.75 |
| History of COPD | 9 (1.0) | 2 (2.2) | 0.58 |
| History of CRF | 15 (1.7) | 5 (5.4) | 0.06 |
| Smoking | 354 (41.2) | 31 (33.3) | 0.28 |
| Total albumin (g/L) | 36.9±10.9 | 38.1±20.1 | 0.60 |
| AST (U/L) | 45.6±88.9 | 54.3±95.1 | 0.63 |
| ALT (U/L) | 39.5±92.2 | 45.0±83.7 | 0.73 |
| Cr (μmol/L) | 115.9±61.5 | 127.7±121.7 | 0.12 |
| BUN (mmol/L) | 9.9±9.2 | 9.5±3.5 | 0.67 |
| Intraoperative variables | |||
| CPBT (min) | 65.2±36.6 | 78.7±54.5 | 0.003 |
| ACCT (min) | 109.4±44.7 | 112.4±41.7 | 0.68 |
| Postoperative variables | |||
| Post-op kidney dysfunction | 206 (24.0) | 38 (40.9) | 0.002 |
| Post-op liver dysfunction | 21 (2.4) | 5 (5.4) | 0.24 |
| Cerebrovascular accident | 9 (1.0) | 6 (6.5) | 0.01 |
| Albumin (g/L) | 34.4±5.3 | 33.1±6.2 | 0.054 |
| Creatinine (μmol/L) | 129.6±69.9 | 139.1±71.7 | 0.22 |
| BUN (mmol/L) | 11.2±7.8 | 11.4±3.9 | 0.59 |
Data are presented as No. (%) or mean ± standard deviation. ACCT, aortic cross-clamp time; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; CPBT, cardiopulmonary bypass time; Cr, blood creatinine; CRF, chronic renal failure; EuroSCORE, European System for Cardiac Operative Risk Evaluation.